Tubeless Insulin Pump Market Regional Analysis:
North America Market Insights
North America industry is likely to account for largest revenue share of 45% by 2035. Product innovations, high disposable income in the population, and rising awareness of advanced diabetic care are drivers of the growth of this region. According to the Centers for Disease Centers (CDC) report (2021) 11.6% of the U.S. population was diagnosed with diabetes. The government's efforts in diabetes care is rising with frequent campaigns being conducted to raise awareness and it has boosted the adoption of tubeless insulin pumps across the country.
In Canada, 5.7 million of the population are diagnosed with type 1 or type 2 diabetes as reported by Diabetes Canada in 2022. Due to the availability of different types of tubeless insulin pumps and presence of well-established healthcare facilities in the U.S. and Canada, both countries are prominent contributors to the North America market.
Asia Pacific Market Insights
Asia Pacific tubeless insulin pump market is expected to record significant growth between 2026-2035. Two of the countries with the highest rate of diabetes are from Asia Pacific i.e. China and India. In 2021, 140.9 million people were diagnosed with diabetes in China while 74.2 million were diagnosed in India. The increasing cases have prompted the governments to invest more in the healthcare sectors and raise initiatives for diabetes care.
The region is also accepting the influx of better technology and innovations. The rate of disposable income in the middle class of countries such as China and India are also rising which allows users to be able to afford advanced diabetic care. These are some of the key drivers that is poised to make the Asia Pacific the fastest-growing market in the tubeless insulin pump sector.
